Chlamydia pneumoniae infection

Chlamydia pneumoniae infection is mainly caused by some infectious diseases caused by Chlamydia pneumoniae, which mainly cause adults or some atypical pneumonia mentioned above, and can cause acute respiratory tract infections such as bronchitis and chronic pharyngitis and tonsillitis. They are all very critical in daily life. Severe cases will mainly cause other types of diseases, so this is also more critical.

There are mainly some acute respiratory infections, mainly manifested as pharyngitis, otolaryngitis, otitis media, bronchitis, pneumonia. However, a small number of patients show high fever and permeability, as well as some myocarditis, endocarditis, forehead infections, arteriosclerosis, coronary heart disease and timeliness.

The pathogen treatment is the same as the other two types of chlamydia infections. It is extremely sensitive to tetracyclines, erythromycin and fluoroquinolones, and resistant to sulfonamides. Therefore, tetracycline or erythromycin is often used, 2g/d, orally in 4 divided doses. Doxycycline 0.1 g/time, 2 times/day can also be used, with a course of treatment of > 3 weeks. Tetracycline and quinolone drugs are contraindicated in pregnant women, lactating women and children. Children (including infants) can use clarithromycin (clarithromycin), which has a better therapeutic effect. Some cases may relapse after stopping medication, especially those treated with erythromycin, and treatment with tetracycline or doxycycline is still effective. In recent years, a new macrolide antibiotic, azithromycin, has been discovered. It shows a high sensitivity reaction to Chlamydia pneumoniae in in vitro drug sensitivity tests, easily enters cells, and the intracellular concentration is 200% of the blood concentration. It has a long half-life. The dosage for adults is 1 g/time, once a day, taken all at once. It has the advantages of high efficiency and low gastrointestinal reactions. Some reports suggest that azithromycin combined with rifampicin is the best treatment for this disease. Multicenter clinical trials have also confirmed that clindamycin 15 mg/(kg·d), erythromycin 50 mg/(kg·d) or azithromycin 10 mg/(kg·d) are effective for children aged 3 to 12 years.

The above is the situation of Chlamydia pneumoniae infection. Some of the onset of the disease at that time is also relevant information. It mainly causes some other inflammations, so the above is also more critical. According to different symptoms and different situations, it also requires some diet. Therefore, in daily life, you must take antibiotics reasonably for two weeks. Collective and personal hygiene are to strengthen environmental hygiene.